Juan Graham - 09 Dec 2022 Form 4/A - Amendment Insider Report for FIBROGEN INC (FGEN)

Role: Chief Financial Officer
Signature: /s/ Cecelia Monoarfa-Taime, Attorney-in-fact
Issuer symbol: FGEN
Transactions as of: 09 Dec 2022
Net transactions value: -$32,031
Form type: 4/A - Amendment
Filing time: 15 Dec 2022, 16:23:46 UTC
Date Of Original Report: 14 Dec 2022
Previous filing: 15 Dec 2022
Next filing: 23 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FGEN	Common Stock	Sale	$11,629	-781	-1.6%	$14.89^*	49,369	09 Dec 2022	Direct	F1, F2
transaction	FGEN	Common Stock	Sale	$20,402	-1,407	-2.8%	$14.50^*	47,962	12 Dec 2022	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.
F2	These shares were sold in multiple transactions on the reported date with prices ranging from $14.667 to $14.8936 resulting in a weighted average price of $14.89. Upon request, the reporting person will provide to the Commission staff or a security holder of the Issuer the number of shares sold and the sale price for each separate transaction.
F3	Shares sold pursuant to a 10b5-1 plan.

Remarks:

This amendment is being file to include the sales price range and to update Column 5 for number of beneficially held shares.